Valuation: Medpace Holdings, Inc.

Market Cap 18.37B 16.61B 15.34B 13.88B 26.2B 1,727B 26.98B 184B 73.15B 923B 68.96B 67.49B 2,939B P/E 2026 *
36x
P/E 2027 * 33.5x
Enterprise Value 17.56B 15.88B 14.66B 13.27B 25.04B 1,651B 25.79B 176B 69.92B 883B 65.91B 64.5B 2,809B EV / Sales 2026 *
6.16x
EV / Sales 2027 * 5.66x
Free-Float
81.14%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week+3.44%
Current month+0.74%
1 month+5.93%
3 months+10.03%
6 months+56.48%
Current year+16.95%
1 week 648.35
Extreme 648.351
679.18
1 month 605.76
Extreme 605.76
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
10/29/26 A Sell

Compliance Officer

-1,245 0.0045%
10/27/26 A Sell

Chief Operating Officer

-3,940 0.0141%
10/21/26 A Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%+3.44%+9.91%+138.54% 18.59B
+1.10%-2.67%+62.79%+70.47% 67.53B
+1.28%+8.71%+13.96%+95.16% 60.74B
+0.36%-0.95%+20.09%+99.04% 55.66B
-0.96%+7.41%+10.20%+108.91% 47.97B
-1.25%+2.35%+22.74%+38.34% 45.24B
-2.41%-0.73%+167.89%+794.72% 39.08B
+1.21%-2.56%+20.27%+52.81% 35.34B
-0.87%-2.89%+79.60%+63.96% 33.45B
-2.22%+8.56%-39.26%+397.14% 26.49B
Average -0.49%+3.28%+36.82%+185.91% 43B
Weighted average by Cap. -0.21%+3.39%+39.08%+165.48%

Financials

2026 *2027 *
Net sales 2.85B 2.58B 2.38B 2.15B 4.06B 268B 4.18B 28.55B 11.35B 143B 10.69B 10.47B 456B 3.02B 2.73B 2.52B 2.28B 4.31B 284B 4.44B 30.27B 12.03B 152B 11.34B 11.1B 483B
Net income 521M 471M 435M 393M 742M 48.94B 764M 5.22B 2.07B 26.16B 1.95B 1.91B 83.27B 554M 501M 462M 418M 790M 52.06B 813M 5.55B 2.2B 27.83B 2.08B 2.03B 88.58B
Net Debt -812M -734M -678M -613M -1.16B -76.3B -1.19B -8.13B -3.23B -40.79B -3.05B -2.98B -130B -1.27B -1.15B -1.06B -961M -1.81B -120B -1.87B -12.75B -5.07B -63.94B -4.77B -4.67B -204B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
12/11/26 $656.84 -1.19% 142,184
11/11/26 $664.77 +0.03% 134,532
10/11/26 $664.54 -1.25% 165,203
09/11/26 $672.93 +3.03% 219,169
06/11/26 $653.11 +2.86% 231,625
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
656.84USD
Average target price
651.31USD
Spread / Average Target
-0.84%
  1. Stock Market
  2. Stocks
  3. MEDP Stock